杆菌和胃癌:机制和新的视角
Yantao Duan1,2, Yonghu Xu1,2, Yi Dou1,2
1Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Journal of hematology & oncology
|January 24, 2025
概括
杆菌 (H. pylori) 感染通过破坏关键分子通路并诱导细胞损伤,显著导致胃癌. 了解这些机制对于制定有效的预防和治疗策略来预防与H. pylori相关的胃癌至关重要.
科学领域:
- 胃肠道学和瘤学
- 微生物学 微生物学
- 分子生物学分子生物学
背景情况:
- 胃癌是全球主要的健康问题,Helicobacter pylori (H. pylori) 感染是主要原因.
- 杆菌影响全球约50%的人口,强调其广泛的影响.
- 几十年的研究已经扩大了我们对H. pylori分子和病原遗传机制的理解.
研究的目的:
- 审查和综合关于H. pylori感染在胃癌发生中的分子机制的最新研究.
- 阐明H. pylori调节失调的分子通路的复杂相互作用.
- 识别当前知识的差距,并建议未来研究的领域.
主要方法:
- 对最近的研究进展进行文献综述.
- 分析涉及关键信号通路 (STAT3,NF-κB,Hippo,Wnt/β-catenin) 的分子机制.
- 研究H. pylori在诱导氧化应激,DNA损伤,炎症和亡方面的作用.
主要成果:
- 皮洛里菌感染对关键的分子通路产生失调,包括STAT3,NF-κB,Hippo和Wnt/β-catenin.
- 杆菌诱导细胞事件,如氧化应激,DNA损伤,慢性炎症和亡,促进癌症发生.
- 新出现的证据表明,H. pylori对瘤微环境的影响及其对癌症免疫治疗的潜在影响.
结论:
- 对H. pylori在胃癌中的作用的全面了解对于促进预防和治疗至关重要.
- 阐明分子机制为与H. pylori相关的胃癌发展提供了更深入的见解.
- 需要进一步的研究,以充分了解H. pylori的影响,并制定有针对性的治疗策略.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
324
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
324
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
535
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
535
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
349
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
349
Gastritis-II: Pathophysiology
229
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
229
Peptic Ulcer Disease I: Introduction
128
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
128
Peptic Ulcer Disease II: Pathophysiology
257
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
257


